167 related articles for article (PubMed ID: 30242208)
1. Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.
Mamand S; Allchin RL; Ahearne MJ; Wagner SD
Sci Rep; 2018 Sep; 8(1):14216. PubMed ID: 30242208
[TBL] [Abstract][Full Text] [Related]
2. Regulation of CXC chemokine receptor 4-mediated migration by the Tec family tyrosine kinase ITK.
Fischer AM; Mercer JC; Iyer A; Ragin MJ; August A
J Biol Chem; 2004 Jul; 279(28):29816-20. PubMed ID: 15123627
[TBL] [Abstract][Full Text] [Related]
3. T cell specific adapter protein (TSAd) interacts with Tec kinase ITK to promote CXCL12 induced migration of human and murine T cells.
Berge T; Sundvold-Gjerstad V; Granum S; Andersen TC; Holthe GB; Claesson-Welsh L; Andreotti AH; Inngjerdingen M; Spurkland A
PLoS One; 2010 Mar; 5(3):e9761. PubMed ID: 20305788
[TBL] [Abstract][Full Text] [Related]
4. Translocation-generated ITK-FER and ITK-SYK fusions induce STAT3 phosphorylation and CD69 expression.
Fathi NN; Mohammad DK; Görgens A; Andaloussi SE; Zain R; Nore BF; Smith CIE
Biochem Biophys Res Commun; 2018 Oct; 504(4):749-752. PubMed ID: 30217447
[TBL] [Abstract][Full Text] [Related]
5. Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma.
Allchin RL; Kelly ME; Mamand S; Doran AG; Keane T; Ahearne MJ; Wagner SD
PLoS One; 2019; 14(4):e0215765. PubMed ID: 31013298
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and structure-activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK).
Wang X; Xue G; Pan Z
Eur J Med Chem; 2020 Feb; 187():111918. PubMed ID: 31830635
[TBL] [Abstract][Full Text] [Related]
7. Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac.
Takesono A; Horai R; Mandai M; Dombroski D; Schwartzberg PL
Curr Biol; 2004 May; 14(10):917-22. PubMed ID: 15186750
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase.
Ottoson NC; Pribila JT; Chan AS; Shimizu Y
J Immunol; 2001 Aug; 167(4):1857-61. PubMed ID: 11489961
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk).
Tang G; Liu L; Wang X; Pan Z
Eur J Med Chem; 2019 Jul; 173():167-183. PubMed ID: 30999237
[TBL] [Abstract][Full Text] [Related]
10. Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.
Guo W; Liu R; Ono Y; Ma AH; Martinez A; Sanchez E; Wang Y; Huang W; Mazloom A; Li J; Ning J; Maverakis E; Lam KS; Kung HJ
Mol Pharmacol; 2012 Nov; 82(5):938-47. PubMed ID: 22899868
[TBL] [Abstract][Full Text] [Related]
11. A FLIPR-based assay to assess potency and selectivity of inhibitors of the TEC family kinases Btk and Itk.
Douhan J; Miyashiro JS; Zhou X; Cole DC; Wu PW; Collins M; Dunussi-Joannopoulos K
Assay Drug Dev Technol; 2007 Dec; 5(6):751-8. PubMed ID: 18181691
[TBL] [Abstract][Full Text] [Related]
12. Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat.
Tanaka N; Abe H; Yagita H; Okumura K; Nakamura M; Sugamura K
Eur J Immunol; 1997 Apr; 27(4):834-41. PubMed ID: 9130632
[TBL] [Abstract][Full Text] [Related]
13. Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.
Gibson S; Truitt K; Lu Y; Lapushin R; Khan H; Imboden JB; Mills GB
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1123-8. PubMed ID: 9494076
[TBL] [Abstract][Full Text] [Related]
14. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
15. IL-2 Inducible Kinase ITK is Critical for HIV-1 Infection of Jurkat T-cells.
Hain A; Krämer M; Linka RM; Nakhaei-Rad S; Ahmadian MR; Häussinger D; Borkhardt A; Münk C
Sci Rep; 2018 Feb; 8(1):3217. PubMed ID: 29453458
[TBL] [Abstract][Full Text] [Related]
16. [Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
Zhan HQ; Zhu XZ; Li XQ; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):32-6. PubMed ID: 21429356
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
Lee BC; Lee TH; Avraham S; Avraham HK
Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
[TBL] [Abstract][Full Text] [Related]
18. The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway.
Li H; Wang C; Ma P; Zhang M; Yang H; Yuan S; Wei J; Tao L; Qian K; Xu M; Li L
J Dermatol Sci; 2020 Mar; 97(3):208-215. PubMed ID: 32165081
[TBL] [Abstract][Full Text] [Related]
19. ITK inhibitors in inflammation and immune-mediated disorders.
Sahu N; August A
Curr Top Med Chem; 2009; 9(8):690-703. PubMed ID: 19689375
[TBL] [Abstract][Full Text] [Related]
20. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
